Literature DB >> 19005607

Synthesis of 3-(carboxyarylalkyl)imidazo[2,1-f][1,2,4]triazines as potential inhibitors of AMP deaminase.

Joseph K Kirkman1, Stephen D Lindell, Simon Maechling, Alexandra M Z Slawin, Christopher J Moody.   

Abstract

C-Ribosyl 1,2,4-triazolo[1,2,4]triazines which are able to undergo covalent hydration are of interest as potential inhibitors of AMP deaminase. In a search for compounds with improved bioavailability we have synthesized compounds in which the sugar has been replaced by carboxyarylalkyl based ribose phosphate mimics. The target carboxyarylalkyl imidazotriazines 11 and 12 were synthesized using a linear seven step sequence starting from simple benzoate derivatives. Alternatively, the hydroxyethyl imidazotriazine 39 is available in five steps and this synthon was used to prepare the imidazotriazines 34 and 48 in a short convergent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005607     DOI: 10.1039/b810850a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.

Authors:  Stephen D Lindell; Simon Maechling; Richard L Sabina
Journal:  ACS Med Chem Lett       Date:  2010-06-18       Impact factor: 4.345

2.  Regioselective synthesis of 7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivatives: A new drug-like heterocyclic scaffold.

Authors:  Nikolay T Tzvetkov; Harald Euler; Christa E Müller
Journal:  Beilstein J Org Chem       Date:  2012-09-20       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.